Crossmark

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

Crossref DOI link: https://doi.org/10.1186/s12943-018-0775-3

Published Online: 2018-02-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Shaocong

Fu, Liwu https://orcid.org/0000-0001-6795-2506
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81473233)

Science and Technology Program of Guangzhou (201504010038, 201604020079, 201601010008)
More Information

Article History

Received: 26 October 2017

Accepted: 1 February 2018

First Online: 19 February 2018

Consent for publication

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.